Comparison of outcomes with elranatamab and real world treatments in the UK for triple class exposed relapsed and refractory multiple myeloma
| Title: | Comparison of outcomes with elranatamab and real world treatments in the UK for triple class exposed relapsed and refractory multiple myeloma |
|---|---|
| Authors: | Tsang, CarmenAff1, IDs12885025146249_cor1; O’Reilly, Joseph E.Aff2; Carpenter, LewisAff2; Duffield, CharlesAff1; Tunaru, FilipaAff2; Wallis, JamieAff2; Perkins, AlyciaAff2; Price, ThomasAff1; Wood, SamAff1; Ramasamy, KarthikAff3 |
| Source: | BMC Cancer. 25(1) |
| Database: | Springer Nature Journals |